stars 1 stars 2 stars 3

DermAvance is a privately held, specialty Aesthetic Dermatology Company that is focused on acquiring and developing both prescription and non-prescription products to improve the appearance of aging skin. DermAvance markets 5 different product lines that include Hyalogy a patented nano-hyaluronic acid topical skin care line, Arnika Forte that is a supplement used to help recovery post surgery or aesthetic procedures, Pur-Sil 100% Medical Grade Silicone for scar recovery, Tret-A an advanced retinoid that contains all-trans retinaldehyde lotion, Hydro-Q 4% gel Rx which contains the active form of hydroquinone to lighten the brown spots in skin.

DermAvance Questions

The DermAvance annual revenue was $6 million in 2026.

Keith Greathouse is the Founder, President and CEO of DermAvance.

2 people are employed at DermAvance.

DermAvance is based in Malvern, Pennsylvania.

The NAICS codes for DermAvance are [32541, 3254, 325, 32].

The SIC codes for DermAvance are [283, 28].

Top DermAvance Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users